Alkyl Amines Q4 FY26 Results: EBITDA Margin Expands, Dividend ₹10

Alkyl Amines Chemicals Limited's Board of Directors, at its meeting held on May 5, 2026 (commencing at 12:30 PM and concluding at 1:50 PM), approved the audited financial results for the quarter and financial year ended March 31, 2026. The board also recommended a final dividend of ₹10 per equity share of ₹2 each (500%) for FY26, subject to shareholder approval at the ensuing Annual General Meeting. The results were reviewed and recommended by the Audit Committee at its meeting held on the same date. Statutory auditor M/s. N. M. Raiji & Co., Chartered Accountants, Mumbai (Registration No. 108296W), represented by Partner Vinay D. Balse (Membership No. 039434), issued an unmodified audit opinion on the financial results. In continuation to the announcement, the audio recording of the earnings conference call held on May 6, 2026, for the audited financial results for the quarter and financial year ended March 31, 2026, has been made available on the Company's website pursuant to Regulation 30 & 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Q4 FY26 and Full-Year Financial Performance

The company reported revenue from operations of ₹386.91 crores for Q4 FY26, marginally higher than ₹386.05 crores in Q4 FY25 and up from ₹354.00 crores in Q3 FY26. For the full year FY26, revenue from operations stood at ₹1,535.85 crores compared to ₹1,571.82 crores in FY25. On an operating profitability basis, Q4 EBITDA improved to 707M rupees from 682M rupees in Q4 FY25, with the EBITDA margin expanding to 18.30% from 17.67% year-on-year, reflecting better cost management during the quarter. The following table summarises the key financial metrics:

Metric: Q4 FY26 Q3 FY26 Q4 FY25 FY26 FY25 Revenue from Operations (₹ Cr): 386.91 354.00 386.05 1,535.85 1,571.82 Other Income (₹ Cr): 8.27 8.01 9.32 31.66 29.80 Total Revenue (₹ Cr): 395.18 362.01 395.37 1,567.51 1,601.62 Total Expenses (₹ Cr): 334.40 304.77 336.02 1,324.04 1,352.98 EBITDA (M Rupees): 707 — 682 — — EBITDA Margin (%): 18.30 — 17.67 — — Profit Before Tax (₹ Cr): 60.78 57.24 59.35 243.47 248.64 Total Tax Expenses (₹ Cr): 15.41 14.98 13.33 63.47 62.53 Net Profit After Tax (₹ Cr): 45.37 42.26 46.02 180.00 186.11 Total Comprehensive Income (₹ Cr): 47.15 42.22 46.40 179.88 184.74 Basic EPS (₹): 8.87 8.26 9.00 35.20 36.40 Diluted EPS (₹): 8.86 8.25 8.99 35.15 36.35

Expense Breakdown

Total expenses for Q4 FY26 stood at ₹334.40 crores against ₹336.02 crores in Q4 FY25, reflecting a marginal improvement. For the full year FY26, total expenses were ₹1,324.04 crores compared to ₹1,352.98 crores in FY25. Key expense components for the quarter and full year are presented below:

Expense Item: Q4 FY26 (₹ Cr) Q4 FY25 (₹ Cr) FY26 (₹ Cr) FY25 (₹ Cr) Cost of Materials Consumed: 186.22 216.77 790.88 834.38 Changes in Inventories: 23.37 (7.84) 28.42 4.40 Employee Benefit Costs: 28.88 24.82 110.15 103.55 Finance Costs: 0.29 0.17 1.17 1.01 Depreciation & Amortisation: 17.89 17.61 71.66 71.23 Other Expenses: 77.75 84.49 321.76 338.41

Balance Sheet Highlights

As at March 31, 2026, total assets stood at ₹1,895.41 crores, up from ₹1,788.85 crores as at March 31, 2025. Total equity increased to ₹1,533.37 crores from ₹1,402.49 crores. Cash and cash equivalents at year-end were ₹94.15 crores, compared to ₹48.78 crores at the beginning of the year. Capital Work-in-Progress rose significantly to ₹130.48 crores from ₹51.91 crores, indicating ongoing capital investment activity. Key balance sheet figures are as follows:

Parameter: March 31, 2026 (₹ Cr) March 31, 2025 (₹ Cr) Total Assets: 1,895.41 1,788.85 Property, Plant & Equipment: 984.31 1,012.50 Capital Work-In-Progress: 130.48 51.91 Inventories: 122.13 164.78 Trade Receivables: 230.50 230.65 Cash & Cash Equivalents: 94.15 48.78 Total Equity: 1,533.37 1,402.49 Total Non-Current Liabilities: 146.19 141.21 Total Current Liabilities: 215.85 245.15

Cash Flow Summary

For FY26, net cash from operating activities was ₹238.55 crores against ₹263.10 crores in FY25. Cash used in investing activities was ₹137.09 crores, primarily driven by purchase of property, plant and equipment including capital work-in-progress of ₹128.41 crores and investment in mutual funds of ₹50.00 crores. Cash used in financing activities was ₹56.09 crores, which included dividend paid of ₹51.15 crores.

Cash Flow Item: FY26 (₹ Cr) FY25 (₹ Cr) Net Cash from Operating Activities: 238.55 263.10 Net Cash used in Investing Activities: (137.09) (195.54) Net Cash used in Financing Activities: (56.09) (49.15) Net Increase in Cash & Equivalents: 45.37 18.41 Closing Cash & Cash Equivalents: 94.15 48.78

Dividend, Conference Call, and Other Disclosures

The Board has recommended a final dividend of ₹10 per equity share of ₹2 each (500%) for FY26, subject to shareholder approval. The audio recording of the earnings conference call held on May 6, 2026, has been made available on the Company's website pursuant to Regulation 30 & 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The trading window for designated persons, their immediate relatives, and connected persons will open from May 8, 2026, following the announcement of audited financial results. The company operates within a single operating segment — Specialty Chemicals — as per IND AS 108. It has no subsidiary, associate, or joint venture entity for FY26 or FY25, and accordingly the results are standalone. The company also restructured employee compensation effective March 1, 2026, in line with the four Labour Codes notified by the Government of India on November 21, 2025; the financial impact, based on actuarial valuation, was assessed as not material. The results were signed by Yogesh M. Kothari, Chairman & Managing Director, and authorized by Chintamani D. Thatte, General Manager (Legal) & Company Secretary & Compliance Officer.

Alkyl Amines Chemicals Limited has officially announced the gradual restart of its ammonia-based product manufacturing operations through a regulatory filing to stock exchanges. The company informed BSE and NSE about the resumption of production activities following improvements in the global ammonia supply situation.

Official Communication and Regulatory Filing

The company submitted its business update under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The communication was signed by Chintamani Thatte, General Manager (Legal) & Company Secretary & Compliance Officer, and addressed to both major Indian stock exchanges.

Exchange Details: Information BSE Scrip Code: 506767 NSE Symbol: ALKYLAMINE Filing Date: April 24, 2026 Regulation: SEBI Regulation 30

Background of Supply Chain Disruptions

The production restart follows the company's earlier disclosure dated March 16, 2026, which highlighted the impact of ongoing geopolitical conflicts in the Middle East. These conflicts had caused substantial disruptions across multiple sectors including logistics networks, global supply chains for crude oil, petrochemicals, and ammonia availability across international markets.

Current Supply Situation and Production Strategy

According to the official filing, while the overall ammonia supply situation continues to remain uncertain and dynamic, conditions have improved sufficiently to enable a gradual restart of ammonia-based product manufacturing.

Production Parameters: Status Overall Ammonia Supply: Uncertain and dynamic Supply Improvement: Sufficient for gradual restart Production Approach: Phased resumption Product Category: Ammonia-based products

Strategic Approach to Recovery

The gradual restart approach demonstrates the company's cautious but optimistic stance toward market recovery. This phased resumption strategy reflects prudent risk management while capitalizing on improving supply chain conditions. The restart represents a positive development for the company's operational capacity and its ability to serve customer demands that were affected during the supply chain disruption period.

The company's proactive communication strategy, providing timely updates on both initial disruptions and subsequent recovery, maintains transparency with stakeholders regarding material developments affecting operations and production capabilities.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.